Top Markets
Coin of the day
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
Pozycja w akcjach #27309
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Cena akcji
$0.89991249
Kapitalizacja rynkowa
$33.67M
Zmiana (1 dzień)
-0.35%
Zmiana (1 rok)
7.33%
Kraj
TW
Handel Prince Pharmaceutical Co., Ltd. (6935)

Kategoria

Historia ceny akcji dla Prince Pharmaceutical Co., Ltd. (6935)
Najwyższa cena zamknięcia: $0.95 dnia 2026-08-01

Najniższa cena zamknięcia: $1.95 dnia 2023-03-01
Historia cen akcji firmy Prince Pharmaceutical Co., Ltd. od 2023 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -2.08%
2025 42.84%
2024 -37.82%
2023 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$160.78 23.58%
DE
$38.00 22.72%
JP
$224.02 35.31%
CH
$20.97 11.75%
IN